The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 Criteria
Authors:
- Teresa RibaltaTRTeresa Ribalta
- Ian E McCutcheonIMIan E McCutcheon
- Kenneth D AldapeKAKenneth D Aldape
- Janet M BrunerJBJanet M Bruner
- Gregory N FullerGFGregory N Fuller
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 28 (11) , 1532-1536
Abstract
Mitotic figure (MF) counting is the most objective criterion for grading of meningiomas according to the 2000 World Health Organization (WHO) classification. However, the search for the area(s) of highest mitotic activity is tedious, and there is high interobserver variability in differentiating MF from apoptotic cells. We tested the utility of the mitosis-specific marker phosphohistone-H3 (PHH3) to enhance rapid recognition of MFs and quick reliable grading of meningioma. Fifty-four archival meningiomas (26 benign, 20 atypical, 8 anaplastic) were reclassified according to current WHO criteria. PHH3-immunostained MFs were counted the same way as in hematoxylin and eosin-stained sections. Anti-PHH3-labeled MFs were easily seen and permitted quick identification of the area(s) of highest mitotic activity. Count results (mean) show a strong correlation between both methods: benign, hematoxylin and eosin 1.4, PHH3 2.2; atypical, hematoxylin and eosin 9.0, PHH3 15.9; anaplastic, hematoxylin and eosin 22.4, PHH3 34.1. PHH3 counting yielded greater sensitivity and in 12 cases (22.2%) suggested a change in grade (increased 9; lowered 3). All cases in which PHH3 lowered the grade were from older blocks, suggesting a loss of antigen preservation. PHH3 immunostaining facilitates the rapid reliable grading of meningiomas by focusing attention on the most mitotically active areas and by allowing easy and objective differentiation of MFs from apoptotic nuclei.Keywords
This publication has 21 references indexed in Scilit:
- Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomasHuman Pathology, 2001
- MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumorsHuman Pathology, 1998
- MIB‐1(Ki‐67) index and transforming growth factor‐alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomasNeuropathology and Applied Neurobiology, 1998
- Chromatin Condensation Is Not Associated with ApoptosisJournal of Biological Chemistry, 1998
- Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosisCytometry, 1998
- Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensationChromosoma, 1997
- Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomasActa Neuropathologica, 1996
- Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomasHuman Pathology, 1996
- Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysisSurgical Neurology, 1986
- Histone Phosphorylation and Chromatin Structure during Mitosis in Chinese Hamster CellsEuropean Journal of Biochemistry, 1978